A detailed history of Mackenzie Financial Corp transactions in Natera, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,225 shares of NTRA stock, worth $539,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,225
Previous 2,923 10.33%
Holding current value
$539,413
Previous $316,000 29.43%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$97.75 - $129.67 $29,520 - $39,160
302 Added 10.33%
3,225 $409,000
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $249,273 - $329,129
2,923 New
2,923 $316,000
Q1 2023

Apr 24, 2023

BUY
$36.57 - $58.29 $258,001 - $411,235
7,055 New
7,055 $391,000
Q2 2021

Aug 11, 2021

SELL
$86.05 - $119.72 $213,576 - $297,145
-2,482 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $227,028 - $308,661
2,482 New
2,482 $252,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.